Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy BIOLASE stock

Own BIOLASE stock in just a few minutes.

BIOLASE, Inc is a medical devices business based in the US. BIOLASE shares (BIOL) are listed on the NASDAQ and all prices are listed in US Dollars. BIOLASE employs 135 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in BIOLASE

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BIOL – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

BIOLASE share price

Use our graph to track the performance of BIOL stocks over time.

BIOLASE shares at a glance

Information last updated 2021-04-30.
52-week range$0.25 - $1.51
50-day moving average $0.87
200-day moving average $0.68
Wall St. target price$1.94
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.98

Buy BIOLASE shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy BIOLASE stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

BIOLASE financials

Revenue TTM $22.8 million
Gross profit TTM $6.2 million
Return on assets TTM -31.8%
Return on equity TTM -234.22%
Profit margin -73.88%
Book value $0.10
Market capitalisation $112.3 million

TTM: trailing 12 months

Shorting BIOLASE shares

There are currently 8.3 million BIOLASE shares held short by investors – that's known as BIOLASE's "short interest". This figure is 2% down from 8.5 million last month.

There are a few different ways that this level of interest in shorting BIOLASE shares can be evaluated.

BIOLASE's "short interest ratio" (SIR)

BIOLASE's "short interest ratio" (SIR) is the quantity of BIOLASE shares currently shorted divided by the average quantity of BIOLASE shares traded daily (recently around 8.4 million). BIOLASE's SIR currently stands at 0.99. In other words for every 100,000 BIOLASE shares traded daily on the market, roughly 990 shares are currently held short.

However BIOLASE's short interest can also be evaluated against the total number of BIOLASE shares, or, against the total number of tradable BIOLASE shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case BIOLASE's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 BIOLASE shares in existence, roughly 60 shares are currently held short) or 0.0561% of the tradable shares (for every 100,000 tradable BIOLASE shares, roughly 56 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against BIOLASE.

Find out more about how you can short BIOLASE stock.

BIOLASE share dividends

We're not expecting BIOLASE to pay a dividend over the next 12 months.

Have BIOLASE's shares ever split?

BIOLASE's shares were split on a 1:5 basis on 10 May 2018. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BIOLASE shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for BIOLASE shares which in turn could have impacted BIOLASE's share price.

BIOLASE share price volatility

Over the last 12 months, BIOLASE's shares have ranged in value from as little as $0.245 up to $1.51. A popular way to gauge a stock's volatility is its "beta".

BIOL.US volatility(beta: 1.5)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BIOLASE's is 1.5019. This would suggest that BIOLASE's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

BIOLASE overview

BIOLASE, Inc. , together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site